Single Ascending Dose Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15912(Sonefpeglutide) in Healthy Korean Subjects
Clinical trial NCT04076293 · COMPLETED
Trial details
- NCT number
- NCT04076293
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-08
- Primary completion
- 2020-11-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.